Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. - Wikidata - awgldk - TriplyDB

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

http://www.wikidata.org/entity/Q35188633

about

Linking form to function: Biophysical aspects of artificial antigen presenting cell design Recent advances in lymphatic targeted drug delivery system for tumor metastasis Sharka: the past, the present and the future Emulsified phosphatidylserine, simple and effective peptide carrier for induction of potent epitope-specific T cell responses The comparison of protein-entrapped liposomes and lipoparticles: preparation, characterization, and efficacy of cellular uptake Maximizing the Supported Bilayer Phenomenon: Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery.Nanoscale artificial antigen presenting cells for T cell immunotherapy Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity.Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.Current and future lymphatic imaging modalities for tumor staging Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases.Lipid nanoparticles for cancer therapy: state of the art and future prospects.Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy.Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals.Nanotechnology applications in diagnosis and treatment of metastasis.Emulsomes meet S-layer proteins: an emerging targeted drug delivery system.Functional liposomes in the cancer-targeted drug delivery.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure.Optical tracer size differences allow quantitation of active pumping rate versus Stokes-Einstein diffusion in lymphatic transport.A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation.Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to rats.Evaluation of systemic exposure of nanoparticle suspensions subcutaneously administered to mice regarding stabilization, volume, location, concentration and size.Comparative pharmacokinetic evaluation of lopinavir and lopinavir-loaded solid lipid nanoparticles in hepatic impaired rat model.Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles.Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics.Design of Bio-nanosystems for Oral Delivery of Functional Compounds

P2860

Q27002652-F72E9037-5A3E-4CF1-A752-AFF9017F4587 Q27005580-E9581838-36E2-41A0-BDAB-E2FB852E5A49 Q27023062-CB94B64D-12E5-4FF4-8115-5F6812C0402D Q27332152-15E9E37C-7125-42B6-8D98-2D644853F5BF Q30409258-28854220-7676-4B03-AD2A-DC2E16B3F9C2 Q33908258-065A6BE7-E17D-4096-B815-B1D8360BBAE2 Q33968408-887C4A99-551D-46AB-B730-F598946D2930 Q34428078-FEA9C412-DBF5-423D-A506-E1469545EDFF Q34571360-6BB9A62D-2356-4BF3-AD23-04C5E25FE952 Q34871801-BC456609-40EF-4078-A1E9-D065ECCAFD93 Q35646297-47769D1D-29DF-48F5-BDE3-08C4ABAF22B4 Q35836140-E28053B7-034F-4181-8C91-B38505A5F09C Q37066550-72A3A79C-ECA7-4812-A6A6-AC71BCF34030 Q37686649-65DAE45C-B8E0-46B2-B818-6C083B8F40D0 Q37731821-409F51FE-0076-41E2-85A3-D03FCD030E44 Q38040884-15F436BE-6BD0-4433-AFB7-2FE3D631D1D0 Q38115195-DBBECF07-6B6B-44E3-B195-C96D6A24B801 Q38123458-D4191E98-5669-4DF3-A584-D9A08D753ED6 Q38242752-738F6EA8-DD29-494E-BFE2-AB0EBA413857 Q38254086-7148AFD9-109F-4003-9438-0EA4FFA12058 Q38361935-DD36D00D-A24B-4626-9A63-DF487A2B216E Q38396298-47545309-45A0-4846-9174-103F91ED17D9 Q38406190-9149F923-1B62-4F5D-B50A-4E777D2A4408 Q38495022-F4F1E365-A6A7-4644-B709-A912FB911246 Q38558905-83BF379D-06ED-4C30-9431-19E3663A6D67 Q38862706-FB62A0A9-8355-437A-A704-7A776CCFE552 Q38926514-B35F78DC-E4B0-4FF2-927C-43F85FE77B17 Q39008671-9028A30B-45AF-485E-AA57-562A9CD19391 Q39013388-1ACDD9C5-122D-49E4-8DBD-9816D2AB63E1 Q39279342-0C45C26C-4417-42F1-A76D-17911FBADEBF Q42227130-CB87DA57-969D-421C-85D2-0A9AC65DA736 Q44888499-161E2875-98E6-4EC6-AD90-5F8A71A1BA1E Q47221355-B982E309-134E-44D5-9675-AAEA58DAE734 Q48106425-6E9C2407-DD6F-4E46-827B-7BAEF8CAF90B Q50778983-154A37CB-81EE-47B2-9E4A-9EE61A906EAF Q54936269-1A7C99AF-E1C4-4F0C-A137-7EA5A93FDB60 Q58356933-CB4D83C3-CB45-4000-B4F5-8E445ED7B622

P2860

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

http://www.wikidata.org/entity/Q35188633

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

@ast

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

@en

type

label

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

@ast

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

@en

prefLabel

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

@ast

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

@en

P1433

Q35188633-94CC708D-FEE7-42F9-8916-48BC5842F871

P1476

Q35188633-03A95AC3-749E-4548-ACA3-82D2617D5CF3

P2093

Q35188633-85FB27ED-783E-462C-8365-25F67280F646

Q35188633-BA73E760-F3FE-4EFB-965A-8C0B3089395A

Q35188633-E6351111-BBE9-473A-BB34-7F5BB176C668

Q35188633-EB83D183-71E7-44EC-8242-1044C22A95B8

P2860

Q35188633-05EAF2DE-8B03-4C4E-A1D1-F6487026B63C

Q35188633-106B27DD-6C38-4B3F-B5CB-A7947AA980EA

Q35188633-137D8373-893A-4EEC-880A-8A6CD5BDD171

Q35188633-1C64B439-DA84-4170-ADCA-BDA7477550E5

Q35188633-20E09E5F-0873-4687-89EB-9662641F87DB

Q35188633-29E2CB4B-DF3A-4039-81D4-490534102981

Q35188633-3361D5C4-014C-4C03-BF3E-17EF3C8061F7

Q35188633-3FBB35C6-5294-4BB2-AAB8-4B167C7FA039

Q35188633-4276C615-F675-4C10-A968-AD15A5593117

Q35188633-43B9C5BC-EFE2-4FEB-8EF5-90069AE12F7E

P304

Q35188633-B02CF796-4B74-4918-A2B3-888D7ED69302

P31

Q35188633-1033DAC4-4BB0-40DC-B8A3-AE864C15FB77

P356

Q35188633-D6AE2A1F-CD29-4B1F-8230-1EC82F981F1D

P407

Q35188633-2FF0A86D-8CFF-4BE4-836B-EA18ED2883D6

P433

Q35188633-999798AC-1E5C-4555-8609-3E3A5FC215CC

P478

Q35188633-DB091DF7-AF0C-4D8B-9EAA-6CAE4F6EF455

P577

Q35188633-D50B8374-4A3F-47F3-B480-04740749A1D5

P5875

Q35188633-EC06C466-2DD8-4FCB-91E4-5313F6F5822F

P698

Q35188633-C1AD84E8-27BF-43ED-8FA8-EC01F2BA1557

P921

Q35188633-9839601F-DBC1-4D36-AD95-C94B3819935F

Q35188633-F3CD3CB9-D1C9-47FE-B2C2-7C9B7285C94B

P932

Q35188633-166602BE-A7DB-45B2-A8D0-1C94CD61A4ED

P356

J.ADDR.2011.05.017

P1433

Advanced Drug Delivery Reviews

P1476

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

@en

P2093

M Laird Forrest

http://www.w3.org/2001/XMLSchema#string

Qiuhong Yang

http://www.w3.org/2001/XMLSchema#string

Shuang Cai

http://www.w3.org/2001/XMLSchema#string

Taryn R Bagby

http://www.w3.org/2001/XMLSchema#string

P2860

Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure.

Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute.

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

Solid lipid nanoparticles: production, characterization and applications.

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

Caelyx/Doxil for the treatment of metastatic ovarian and breast cancer.

Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.

[(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model.

Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis.

Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.

P304

901-908

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ADDR.2011.05.017

http://www.w3.org/2001/XMLSchema#string

P407

P433

10-11

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51450960

http://www.w3.org/2001/XMLSchema#string

P698

21712055

http://www.w3.org/2001/XMLSchema#string

P921

P932

3164476

http://www.w3.org/2001/XMLSchema#string